Valproate PPP in ID — MRCPsych Paper B MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: D — Use the Pregnancy Prevention Programme, involving a responsible person where appropriate, with pregnancy testing, effective contraception and annual specialist review.
The correct answer is D. Intellectual disability and lack of capacity do not themselves prohibit valproate, nor do they exempt a patient from its reproductive-risk safeguards. Because pregnancy is possible, the UK Pregnancy Prevention Programme (PPP) must be fulfilled. Current MHRA materials permit discussion and risk acknowledgement with a responsible person for a patient who lacks capacity, alongside accessible involvement of the patient wherever possible. The PPP includes excluding pregnancy before initiation, effective contraception throughout treatment where relevant, risk documentation and at least annual specialist review. The two-specialist decision is an additional requirement for a new female patient under 55 years; it does not replace the PPP. A incorrectly treats incapacity as an absolute contraindication. C wrongly assumes intellectual disability eliminates pregnancy risk. D delays mandatory safeguards. E conflates separate regulatory requirements.
Reference: Medicines and Healthcare products Regulatory Agency / eMC. Valproate: Annual Risk Acknowledgement Form for Female Patients, version 2.0, May 2025. https://www.medicines.org.uk/emc/rmm/2522/Document